Showing results (551-560 of 608) with videos related to
Sort By:
Pageof 61
Nature Communications|August 28, 2013
Extraordinary phylogenetic diversity and metabolic versatility in aquifer sedimentCindy J Castelle, Laura A Hug, Kelly C Wrighton, et al.Journal of Applied Toxicology : JAT|June 29, 2001
Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant modelR P Casillas, R C Kiser, J A Truxall, et al.Geobiology|April 16, 2014
Identification of Desulfobacterales as primary hydrogenotrophs in a complex microbial mat communityL C Burow, D Woebken, I P G Marshall, et al.Journal of Proteome Research|December 16, 2014
Changes in protein expression across laboratory and field experiments in Geobacter bemidjiensisEric D Merkley, Kelly C Wrighton, Cindy J Castelle, et al.Bone Marrow Transplantation|February 16, 2000
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study GroupA F List, R Maziarz, P Stiff, et al.JAMA Network Open|November 19, 2025
Hepatitis B Virus Treatment Gaps in the USRobert J Wong, Laura E Telep, Charles E Wentworth, et al.Biotechnology for Biofuels|October 16, 2020
Development of genetic tools for the thermophilic filamentous fungus Thermoascus aurantiacusRaphael Gabriel, Julia Prinz, Marina Jecmenica, et al.Oncogene|March 1, 2005
Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitorsTeru Hideshima, Dharminder Chauhan, Kenji Ishitsuka, et al.Cancer Research|December 18, 2003
Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myelomaTeru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, et al.British Journal of Haematology|November 17, 2015
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDSRaya Mawad, Pamela S Becker, Paul Hendrie, et al.Pageof 61